Tideglusib, a Non-ATP Competitive Inhibitor of GSK-3β as a Drug Candidate for the Treatment of Amyotrophic Lateral SclerosisLoreto Martínez‐González, Ana Martı́nez, Gracia Porras et al.|International Journal of Molecular Sciences|2021Cited by 67
Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral sclerosisElisa Rojas‐Prats, Ana Martı́nez, Loreto Martínez‐González et al.|European Journal of Medicinal Chemistry|2020Cited by 48
TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis TherapyVanesa Nozal, Ana Martı́nez, Eva de Lago et al.|Journal of Medicinal Chemistry|2022Cited by 45